Yang Qu

1.6k total citations
53 papers, 1.0k citations indexed

About

Yang Qu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yang Qu has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 16 papers in Surgery. Recurrent topics in Yang Qu's work include Renal cell carcinoma treatment (23 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Renal and related cancers (10 papers). Yang Qu is often cited by papers focused on Renal cell carcinoma treatment (23 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Renal and related cancers (10 papers). Yang Qu collaborates with scholars based in China, United States and Japan. Yang Qu's co-authors include Li Liu, Jianming Guo, Ying Xiong, Jiejie Xu, Yu Xia, Qi Bai, Jinggang Xia, Hui Li, Gang Zhao and Zhiyuan Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Journal of Urology.

In The Last Decade

Yang Qu

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Qu China 16 433 376 302 287 185 53 1.0k
Jiachen Xu China 17 357 0.8× 562 1.5× 256 0.8× 208 0.7× 141 0.8× 51 1.0k
Satoshi Muto Japan 18 311 0.7× 406 1.1× 246 0.8× 229 0.8× 121 0.7× 72 898
Olli Helminen Finland 20 319 0.7× 384 1.0× 156 0.5× 255 0.9× 497 2.7× 90 1.1k
Hiroyuki Takamura Japan 13 350 0.8× 222 0.6× 213 0.7× 74 0.3× 162 0.9× 56 875
Hirohisa Hirabayashi Japan 13 219 0.5× 462 1.2× 339 1.1× 191 0.7× 117 0.6× 28 979
Sook-Whan Sung South Korea 15 492 1.1× 214 0.6× 169 0.6× 77 0.3× 270 1.5× 26 763
Prakash Kharel United States 6 205 0.5× 739 2.0× 249 0.8× 342 1.2× 60 0.3× 13 1.0k
Yutaka Kurebayashi Japan 16 259 0.6× 401 1.1× 356 1.2× 588 2.0× 92 0.5× 42 1.3k
Yun–Jie Gao China 20 313 0.7× 175 0.5× 200 0.7× 97 0.3× 544 2.9× 48 1.1k
Ching-Liang Ho Taiwan 13 451 1.0× 475 1.3× 251 0.8× 140 0.5× 116 0.6× 27 923

Countries citing papers authored by Yang Qu

Since Specialization
Citations

This map shows the geographic impact of Yang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Qu more than expected).

Fields of papers citing papers by Yang Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Qu. The network helps show where Yang Qu may publish in the future.

Co-authorship network of co-authors of Yang Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Qu. A scholar is included among the top collaborators of Yang Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Qu. Yang Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yihan, et al.. (2024). YAP enhances mitochondrial OXPHOS in tumor-infiltrating Treg through upregulating Lars2 on stiff matrix. Journal for ImmunoTherapy of Cancer. 12(11). e010463–e010463. 5 indexed citations
2.
Kong, Weiqing, et al.. (2023). Nomogram for predicting venous thromboembolism after spinal surgery. European Spine Journal. 33(3). 1098–1108. 3 indexed citations
3.
Peng, Yan, et al.. (2022). Hsa_circ_0134111 promotes intervertebral disc degeneration via sponging miR-578. Cell Death Discovery. 8(1). 55–55. 11 indexed citations
4.
Xiong, Ying, Li Liu, Yu Xia, et al.. (2019). Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma. Cancer Immunology Immunotherapy. 68(5). 731–741. 40 indexed citations
5.
Bi, Yalan, Yang Qu, Zhiyong Liang, et al.. (2018). Clinicopathological analysis of Large Cell Lung Carcinomas definitely diagnosed according to the New World Health Organization Criteria. Pathology - Research and Practice. 214(4). 555–559. 5 indexed citations
6.
Liu, Li, Yu Xia, Jiajun Wang, et al.. (2018). A preliminary study on classification and therapeutic strategies for spontaneous perirenal hemorrhage. International Journal of Surgery. 54(Pt A). 86–91. 6 indexed citations
7.
Kameda, Koji, Takashi Eguchi, Shaohua Lu, et al.. (2018). Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma. Journal of Thoracic Oncology. 13(12). 1919–1929. 35 indexed citations
8.
Qu, Yang, Haifeng Lin, Chen Zhang, Kun Li, & Haiqing Zhang. (2018). Cribriform pattern in lung invasive adenocarcinoma correlates with poor prognosis in a Chinese cohort. Pathology - Research and Practice. 215(2). 347–353. 14 indexed citations
9.
Yang, Bo, Tingjun Liu, Yang Qu, et al.. (2018). Progresses and Perspectives of Anti-PD-1/PD-L1 Antibody Therapy in Head and Neck Cancers. Frontiers in Oncology. 8. 563–563. 31 indexed citations
10.
11.
Wang, Jiajun, Li Liu, Yang Qu, et al.. (2017). HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients. Cancer Immunology Immunotherapy. 67(1). 79–87. 5 indexed citations
12.
Xiong, Ying, Li Liu, Yu Xia, et al.. (2017). Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma. BMC Cancer. 17(1). 117–117. 10 indexed citations
13.
Xia, Yu, Li Liu, Qi Bai, et al.. (2016). Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma. Scientific Reports. 6(1). 32657–32657. 16 indexed citations
15.
Che, Nanying, et al.. (2015). Double staining of bacilli and antigen Ag85B improves the accuracy of the pathological diagnosis of pulmonary tuberculosis. Journal of Clinical Pathology. 69(7). 600–606. 15 indexed citations
16.
Qu, Yang, Dan Zhao, Jing Mu, et al.. (2015). Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study. Tumor Biology. 37(1). 887–896. 8 indexed citations
17.
Qu, Yang, Nanying Che, Dan Zhao, et al.. (2015). The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma. Tumor Biology. 36(8). 6417–6424. 15 indexed citations
18.
Xia, Jinggang, et al.. (2015). Preoperative Rosuvastatin Protects Patients with Coronary Artery Disease Undergoing Noncardiac Surgery. Cardiology. 131(1). 30–37. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026